-
14 April 2026 08:00:32
- Source: Sharecast
GS CHAIN PLC
("GS Chain" or the "Company")
Allotment and Admission of New Shares
GS Chain Plc, a UK company admitted to the Equity Shares (Shell Companies) category of the Official List of the Financial Conduct Authority (the "Official List") and to the main market of the London Stock Exchange Group Plc ("Main Market"), is pleased to announce that further to the announcement made by the Company on 4 March 2026 regarding the termination and settlement agreement entered into with Citymeade Limited in relation to the Convertible Investment Agreement dated 15 October 2025 ("Investment Agreement"), the following additional information is disclosed in accordance with The Public Offers and Admissions to Trading Regulations 2024 (POATRs) PRM 1.6.4R.
|
1. |
Details of the issuer: |
|
|
(a) |
Name |
GS Chain Plc |
|
(b) |
LEI |
984500K398M8C508B642 |
|
2. |
Details of the transferable securities admitted to trading: |
|
|
(a) |
Name, type and identification code |
Ordinary shares of £0.000167 each;
ISIN: GB00BP38X172 |
|
(b) |
Regulated market |
London Stock Exchange Plc's main market for listed securities |
|
(c) |
Number of further securities admitted |
48,000,000 |
|
(d) |
Total number of securities in issue following admission |
447,985,888 |
|
(e) |
Fungibility |
Fully fungible with existing ordinary shares |
|
3. |
Admission details: |
|
|
(a) |
Date of admission |
17 April 2026 |
Application has been made for the 48,000,000 shares, issued pursuant to the Investment Agreement ("New Shares") to be admitted to trading on the main market for listed securities of the London Stock Exchange Plc ("Admission").
Notwithstanding such application, dealings in the Company's ordinary shares remain suspended and therefore dealings in the New Shares will not commence until the publication by the Company of an FCA approved prospectus in relation to its initial transaction, announced on 17 February 2026, or an announcement that such initial transaction is not proceeding and the suspension is subsequently lifted.
The New Shares will rank pari passu in all respects with the existing ordinary shares of the Company.
Following Admission, the Company's issued share capital will consist of 447,985,888 ordinary shares of £0.000167 each. The Company does not hold any ordinary shares in treasury. Accordingly, the total number of voting rights in the Company will be 447,985,888. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
The issue of the New Shares constitutes full and final settlement of the obligations of the Company under the Investment Agreement, which has therefore terminated in accordance with the terms of the termination and settlement agreement announced on 4 March 2026.
- Ends -
For further information please contact:
|
Paul Carroll, Director |
Paul@gschain.com |
|
Bowsprit Partners Limited, Financial Adviser John Treacy / Luis Brime |
+44 (0)203 883 4430 |
Caution regarding forward looking statement:
Certain statements in this announcement, are, or may be deemed to be, forward looking statements. Forward looking statements are identified by their use of terms and phrases such as ''believe'', ''could'', "should" ''envisage'', ''estimate'', ''intend'', ''may'', ''plan'', ''potentially'', "expect", ''will'' or the negative of those, variations or comparable expressions, including references to assumptions. These forward-looking statements are not based on historical facts but rather on the Directors' current expectations and assumptions regarding the Company's future growth, results of operations, performance, future capital and other expenditures (including the amount, nature and sources of funding thereof), competitive advantages, business prospects and opportunities. Such forward-looking statements reflect the Directors' current beliefs and assumptions and are based on information currently available to the Directors.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.